Bradley Scroggins, PhD

Program Director

Translational Research Program

Division of Cancer Treatment and Diagnosis
National Cancer Institute
9609 Medical Center Drive, Room 3W114
MSC 9726
Bethesda, MD 20892
Phone (240) 276-7860
Fax (240) 276-7881
Email: bradley.scroggins@nih.gov

Portfolios: Bladder, and Prostate

Bradley Scroggins, PhD is a Program Director at the Translational Research Program within the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Scroggins obtained his PhD in Biochemistry and Molecular Biology at Oklahoma State University. His postdoctoral training was with the NCI Urologic Oncology Branch. Dr. Scroggins was a biologist for 11 years in the NCI Radiation Oncology Branch Intramural Program. Dr. Scroggins has gained scientific and technical expertise developing preclinical models of prostate, bladder, and kidney cancer as well as studies in radiation oncology, mitigation of radiation damage to normal tissue, molecular chaperone and protein homeostasis. Dr. Scroggins joined the Translational Research Program in 2023.